Related Experiment Video
Updated: Jun 11, 2026
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
Cell-based assays: fuelling drug discovery
Elisa Michelini1, Luca Cevenini, Laura Mezzanotte
1Department of Pharmaceutical Sciences, University of Bologna, Via Mentana, 7, 40126 Bologna, Italy.
Analytical and Bioanalytical Chemistry
|July 13, 2010
Summary
Cell-based assays accelerate early drug discovery by providing vital information on drug candidates. This review explores their benefits and challenges for efficient new medicine development.
Area of Science:
- Drug discovery and development
- Cellular biology
- Pharmacology
Background:
- High costs and low approval rates necessitate efficient early-stage drug discovery.
- Understanding biological activity, toxicity, and mechanisms is crucial for drug candidates.
- Cell-based assays offer advantages in predictability, automation, multiplexing, and miniaturization.
Purpose of the Study:
- To review the advantages and limitations of cell-based assays in early drug discovery.
- To discuss current challenges and future trends in cellular screening.
Main Methods:
- Review of various cell-based assay strategies, including reporter gene technology and protein fragment complementation assays.
- Analysis of the strengths and weaknesses of different cell-based approaches.
Main Results:
- Cell-based assays are powerful tools for early drug discovery, offering predictability and automation.
- Challenges remain in cellular screening despite various available strategies.
- The field is rapidly evolving with new directions and trends.
Conclusions:
- Cell-based assays are indispensable for efficient early-stage drug discovery.
- Addressing current challenges will further enhance the utility of these assays.
- Future trends promise more sophisticated and informative cellular screening methods.
